Singapore: He appointed as CEO at Cargene

Cargene Biopharma, a biopharmaceutical company developing oligonucleotide therapeutics for liver and ophthalmic disorders, has appointed Kathy He as CEO and member of the board. He, a seasoned biopharmaceutical industry executive, brings over 20 years of R&D and commercial experience from multiple global companies to her new role at Cargene, notably in building differentiated product portfolios,…